(MedPage Today) — ORLANDO — A year of combination therapy for previously untreated chronic lymphocytic leukemia (CLL) patients led to similar outcomes compared with indefinite BTK inhibition with ibrutinib (Imbruvica) alone, an interim analysis…
Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118873
Author :
Publish date : 2025-12-07 13:22:00
Copyright for syndicated content belongs to the linked Source.
